Research Labs

Share
Print
and/or
186 Faculty Members found
Molecular Pharmacology Program
Cancer Biology & Genetics Program
Robert Benezra Lab Group
Robert Benezra, PhD
Cancer biologist Robert Benezra studies the molecular mechanisms of tumor growth and metastatic progression using mouse models. In addition, he studies the spindle assembly checkpoint which ensures proper chromosome segregation and is often deregulated in cancer.
Human Oncology & Pathogenesis Program
Researchers in the Berger laboratory
Michael F. Berger, PhD
Researcher Michael Berger focuses on massively parallel sequencing of tumor DNA for biomarker discovery and clinical diagnostics.
Developmental Biology Program
Pictured: Peter Besmer Lab group photo
Peter Besmer, PhD
The Peter Besmer laboratory focuses on normal and oncogenic receptor tyrosine kinase signaling in vitro and in vivo in mice.
Molecular Pharmacology Program
The Blasberg Lab Group
Ronald G. Blasberg, MD
Physician-scientist Ronald Blasberg focuses on the development of noninvasive imaging paradigms in living organisms using radionuclide and optical reporter systems.
Human Oncology & Pathogenesis Program
The Adrienne Boire Lab
Adrienne A. Boire, MD, PhD
Physician-scientist Adrienne Boire studies metastasis to the central nervous system.
Memorial Hospital Research Laboratories
Michelle Bradbury Lab Group
Michelle S. Bradbury, MD, PhD
Clinician-scientist Michelle Bradbury develops translational, tumor-targeting, PET-optical silica nanoparticle probes for diagnostics, drug delivery, and sensing.
Chemical Biology Program
The Sean Brady Lab @ Rockefeller.edu
Sean Brady, PhD
Sean Brady's research interests center on both the discovery and the functional characterization of new small molecules from previously inaccessible genetic sources.
Memorial Hospital Research Laboratories
The Brennan Lab
Cameron W. Brennan, MD
Physician-scientist Cameron Brennan focuses on genomic analysis of human and mouse gliomas and medulloblastomas.
Human Oncology & Pathogenesis Program
The Renier Brentjens Lab
Renier J. Brentjens, MD, PhD
Physician-scientist Renier Brentjens develops novel immunotherapies for leukemias and lymphomas.